Fecal glycoprotein 2 is a marker of gut microbiota dysbiosis and systemic inflammation

Fabian Frost,Stefan Weiss,Johannes Hertel,Malte Rühlemann,Corinna Bang,Andre Franke,Matthias Nauck,Marcus Dörr,Henry Völzke,Dirk Roggenbuck,Peter Schierack,Uwe Völker,Georg Homuth,Ali A. Aghdassi,Matthias Sendler,Markus M. Lerch,Frank U. Weiss
DOI: https://doi.org/10.1186/s13099-024-00657-1
2024-10-21
Gut Pathogens
Abstract:Antimicrobial autoantigenic glycoprotein 2 (GP2) is an important component of the innate immune system which originates from the exocrine pancreas as well as from the small intestines. The relationship of GP2 with the intestinal microbiome as well as the systemic implications of increased fecal GP2 levels are, however, still unclear. Therefore, fecal samples from 2,812 individuals of the Study of Health in Pomerania (SHIP) were collected to determine GP2 levels (enzyme-linked immunosorbent assay) and gut microbiota profiles (16 S rRNA gene sequencing). These data were correlated and associated with highly standardised and comprehensive phenotypic data of the study participants.
gastroenterology & hepatology,microbiology
What problem does this paper attempt to address?